![Yuval Cohen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Yuval Cohen
Chief Executive Officer at
CORBUS PHARMACEUTICALS HOLDINGS, INC.
Net worth: 340 184 $ as of 2026-06-29
Profile
Yuval Cohen was the founder of Celsus Therapeutics Plc, founded in 2005, and held the title of Director & Senior Vice President in 2013.
Dr. Cohen currently holds the positions of Chief Executive Officer & Director at Corbus Pharmaceuticals, Inc. since 2013, and Chief Executive Officer & Director at Corbus Pharmaceuticals Holdings, Inc. since 2014.
Dr. Cohen's education includes an undergraduate degree from the University of Cape Town and a doctorate from Université de Paris 5 René Descartes.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-03-22 | 36,267 ( 0.2% ) | 340 184 $ | 2026-06-29 |
Yuval Cohen active positions
| Companies | Position | Start |
|---|---|---|
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Chief Executive Officer | 2014-04-10 |
Corbus Pharmaceuticals, Inc.
 Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Chief Executive Officer | 2013-06-30 |
Former positions of Yuval Cohen
| Companies | Position | End |
|---|---|---|
Celsus Therapeutics Plc
 Celsus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops novel non steroidal anti-inflammatory drugs | Founder | 2013-11-30 |
Training of Yuval Cohen
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
43
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Celsus Therapeutics Plc
Celsus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops novel non steroidal anti-inflammatory drugs | Health Technology |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
University of Cape Town
 University of Cape Town Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Université de Paris 5 René Descartes
 Université de Paris 5 René Descartes Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Corbus Pharmaceuticals Holdings, Inc.
 Corbus Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases | Health Technology |
- Stock Market
- Insiders
- Yuval Cohen
